Drugs / IRDye800CW-exendin-4
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04733508 | Nov 2019 → Jun 2022 | type 2 diabetes mellitus | Radboud University Medical Center | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IRDye800CW-exendin-4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04733508 ↗ |
| Modality | Diagnostic / imaging agent | “localization of the tracer in excised pancreatic tissue using fluorescence microscopy” NCT04733508 ↗ |
| Route | Other | “Injection of IRDye800CW-exendin-4” NCT04733508 ↗ |